Investigation of the PDZ domain ligand binding site using chemically modified peptides

Kathleen A.P. Novak, Naoaki Fujii, R. Kiplin Guy

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Several chemically modified analogues to a tightly binding ligand for the second PDZ domain of MAGI-3 were synthesized and evaluated for their ability to compete with native peptide ligands. N-methyl scanning of the ligand backbone amides revealed the energetically important hydrogen bonds between the ligand backbone and the PDZ domain. Analogues to the ligand's conserved threonine/serine(-2) residue, involved in a side chain to side chain hydrogen bond with a conserved histidine in the PDZ domain, revealed that the interaction is highly sensitive to the steric structure around the hydroxyl group of this residue. Analogues of the ligand carboxy terminus revealed that the full hydrogen bond network of the GLGF loop is important in ligand binding.

Original languageEnglish
Pages (from-to)2471-2474
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Issue number17
StatePublished - Sep 2 2002

Bibliographical note

Funding Information:
We thank the Sidney Kimmel Foundation for Cancer Research, the HHMI Research Program (Grant # 76296–549901) and UCSF for financial assistance.

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry


Dive into the research topics of 'Investigation of the PDZ domain ligand binding site using chemically modified peptides'. Together they form a unique fingerprint.

Cite this